Industry: Life sciences:

clinical trials risk management

Why Do Most Clinical Trials Run Late?

Posted 22 April 2014 | 0 Comments

There is widespread agreement across the pharmaceutical industry that the vast majority of trials fail to meet their timeline targets. This article makes the case that a significant part of the answer may lie in the inability of both sponsors... Read More

risk management in life sciences

Mature Approach to Risk Management in Life Sciences

Posted 22 February 2012 | 0 Comments

In an increasingly competitive and cost-sensitive environment, CROs need to be better informed on how risky a particular bid price might be (the probability of making a profit or loss). As well as the confidence of achieving milestones. Or risk... Read More

Supply Chain Risk Management

No Risk, No reward – Outsourcing the supply chain

Posted 30 November 2011 | 0 Comments

Pharmaceutical-technology.com – November 2011 Although pharmaceutical companies rely heavily on contractors, the industry is still new to the world of outsourcing. Risk management strategies across parts of the pharmaceutical supply chain remain surprisingly unsophisticated. Elly Earls finds out why openness,... Read More